$AGEN 4/A SEC Filings

Filed On	Filing
26 May 2023	Form 4/A: Agenus Inc, 10% owner · Mink Therapeutics Inc Holds 21,476,531 shares of Common Stock
26 May 2023	Form 4/A: Agenus Inc, 10% owner · Mink Therapeutics Inc Disposed of 5,006,397 shares (Other Transaction)
05 Jan 2021	Form 4/A: Armen Garo H, Director Received 4,676 shares as a grant or award ($14.9K)
10 Jan 2020	Form 4/A: Armen Garo H, Director Acquired 66,000 shares (Other Transaction) ($256K) · Disposed of 66,000 shares (Other Transaction) ($256K) · Disposed of 195,358 shares (Other Transaction) ($736K)
02 Jul 2018	Form 4/A: Klaskin Christine M, VP Finance Granted 83,150 Stock Option, right to buy ($470K)
19 Jan 2018	Form 4/A: Wright Timothy, Director Granted 1,944.802 Deferred Shares ($7.56K)
19 Jan 2018	Form 4/A: Jordan Wadih, Director Granted 5,271.859 Deferred Shares ($20.5K)
31 Oct 2017	Form 4/A: Armen Garo H, Chairman & CEO Bought 59,612 shares ($209K) · Bought 40,388 shares ($146K)
13 May 2016	Form 4/A: Armen Garo H, Chairman and CEO Received 71,964 shares as a grant or award ($299K) · Returned 26,714 shares to the issuer ($111K)
13 May 2016	Form 4/A: Klaskin Christine M, VP Finance Received 10,429 shares as a grant or award ($43.3K) · Returned 3,553 shares to the issuer ($14.7K)
13 May 2016	Form 4/A: Valentine Karen, Chief Legal Officer Received 24,822 shares as a grant or award ($103K) · Returned 8,068 shares to the issuer ($33.5K)
13 May 2016	Form 4/A: Ballantyne Charles Evan, Chief Financial Officer Received 21,902 shares as a grant or award ($90.9K) · Returned 7,107 shares to the issuer ($29.5K)
13 May 2016	Form 4/A: Baysal Ozer, Chief Business Officer Received 13,078 shares as a grant or award ($54.3K) · Returned 3,545 shares to the issuer ($14.7K)
13 May 2016	Form 4/A: Stein Robert Benjamin, President R&D Received 33,375 shares as a grant or award ($139K) · Acquired 12,389 shares (Disposition to Issuer) ($51.4K)
13 May 2016	Form 4/A: Valentine Karen, Chief Legal Officer Received 24,822 shares as a grant or award ($103K) · Acquired 8,068 shares (Disposition to Issuer) ($33.5K)
10 May 2016	Form 4/A: Armen Garo H, Chairman & CEO Bought 50,000 shares ($154K) · Bought 50,000 shares ($164K)
29 Sep 2015	Form 4/A: Armen Garo H, Chairman & CEO Holds 1,309,607 shares of Common Stock
30 Apr 2014	Form 4/A: Armen Garo H, Chairman and CEO Acquired 39,854 shares (Other Transaction) ($96K)
22 Jun 2012	Form 4/A: Klaskin Christine M, VP Finance Received 7,456 shares as a grant or award ($39.2K)
29 Dec 2011	Form 4/A: Klaskin Christine M, VP, Finance Sold 1,824 shares ($3.9K) · Sold 1,095 shares ($2.29K) · Sold 6,391 shares ($12.8K)

Comments